tirzepatide medical clinic 💉 is now being discussed in the Philippines as a medication for weight loss and Type 2 diabetes management — but is it right for you? Originally developed for Type 2 Tirzepatide | Wellness Center in

There has been a notable increase in the number of patients with T2DM due to the global rise in obesity, driven by sedentary lifestyles and regular consumption of energy-dense diets (Gupta et al., 2024

The good news is, if you lose a substantial amount of weight, visceral fat around the organsincluding the liver, kidney, and heartwill be reduced, which can help these organs function better, Apovian says

Clinical outcomes: In the STEP 1 clinical trial, participants using semaglutide 2.4 mg (Wegovy) lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group

The risk-benefit profile is completely different in those groups. Food, Dushay emphasized, is not tobacco